Translation of proteins accounting for the full coding capacity of the semliki forest virus 42 S RNA genome  by Glanville, Niall & Lachmi, Bat-El
Volume 8 1. number 2 FEBS LETTERS September 1977 
TRANSLATION OF PROTEINS ACCOUNTING FOR THE FULL CODING CAPACITY OF 
THE SEMLIKI FOREST VIRUS 42 S RNA GENOME 
Niall GLANVILLE and Bat-El LACHMI+ 
Department of Virology, University of Helsinki SF-00290 Helsinki 29, Finland 
Received 30 June 1977 
1. Introduction 
Cell-free translation has been widely used to define 
the proteins encoded by, for example, viral messenger 
RNAs. In cells infected with alphaviruses (e.g., Semliki 
Forest and Sindbis viruses) there are two major viral 
RNA species, the genomic 42 S RNA (mol. wt 
4-4.5 X 10”) and the intracellular 26 SRNA (mol. wt 
1.6 X 106) [1,2], which is a copy of the 3’ third of the 
42 S RNA [3,4]. The 26 S RNA has been shown by 
cell-free translation to encode the structural proteins 
of the virion, which are synthesised as a polyprotein, 
~130 (mol. wt 130 000) [5-91. This leaves about 
300 000 daltons of the potential coding capacity of 
the 42 S RNA unaccounted for. 
Using a temperature-sensitive mutant of Semliki 
Forest virus (ts-1), nonstructural (ns) proteins have 
been identified. Two precursor proteins, ns155 and 
ns135 (mol. wt 155 000 and 135 000, respectively) are 
translated sequentially, probably as a polyprotein, 
and cleaved to give four, more stable nonstructural 
proteins [lo,1 11. Corresponding proteins and their 
precursors have subsequently been detected in wild 
type virus infected cells [ 121. If the mutant induced 
nonstructural precursor proteins, nsl55 and ns 135, 
have different amino acid sequences, and are in fact 
virus coded, they, together with the structural poly- 
protein, ~130, would occupy virtually the full coding 
capacity of the SFV genome. Here we have compared 
the tryptic peptides derived from the mutant-induced 
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proteins and those from the cell-free translation 
product directed by the wild type 42 S RNA. The 
results show ns155,ns135 and ~130 to be distinct 
entities, and further that ns155 and at least part of 
ns135 are translated from wild type 42 S RNA 
in vitro. 
2. Materials and methods 
Growth and purification of SFV and isolation of 
virion 42 S RNA have been described [8]. Conditions 
for cell-free protein synthesis using a wheat germ 
extract were identical to those used earlier [13,14]. 
Addition of exogenous wild type 42 S RNA to the 
reaction resulted in a lo-20-fold increase in hot acid 
insoluble [35S]methionine radioactivity. The labelling 
and purification of large amounts of proteins from 
SFV ts-mutant infected cells by discontinuous sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis, 
and preparation of these proteins for tryptic peptide 
analysis is detailed elsewhere [9,11]. The cell-free 
protein-synthesising reactions were processed as 
described [8,15]. Conditions for tryptic digestion and 
high voltage paper elecrophoresis were as reported 
[ 1 I]. [35S]Methionine was the radioactive label used 
throughout this study. 
3. Results and discussion 
The short-lived precursor proteins, ns15 5 and ns135 
which have been identified previously [lo], were 
isolated from cells infected with our SFV mutant, ts-1 , 
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Fig.1. Tryptic peptide maps of [“‘S]methionine containing peptides derived from SFV ts-mutant induced proteins and a cell-free 
protein synthesising system programmed with wild type 42 S RNA: (A) ns155 and (B) ns135 were prepared from cells infected 
with ts-1. (C) Peptides derived from the 42 S RNA directed in vitro product after precipitation with TCA. (D) ~130 from cells 
infected with ts-3. Electrophoresis was on Whatman 3 MM paper, in the first dimension (horizontal) at pH 6.5, for 120 min at 
40 V/cm; origin near middle, cathode at left. Electrophoresis in the second dimension (upwards) was at pH 3.5 for 90 min at 
60 V/cm, cathode at top. Autoradiography was for 21 days, (A), (B) and (D), or 10 days, (C). Longer exposure (19 days) of the 
central part of the map indicated in (C) is shown in the inset. (---&) Peptides, nsl35-derived, detected in the in vitro product. 
( -I>) Possible ‘lead-in’ peptides found only in the in vitro product (see text). ( A ) Peptides also detected in control cell-free 
incubations (with no added RNA). 
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by polyacrylamide gel electrophoresis, eluted from the 
gel, and digested with trypsin. The tryptic peptide maps 
obtained from these [35S]methionine labelled proteins 
by high voltage paper electrophoresis are shown in 
fig.l(A) and (B). They are clearly different, showing 
the proteins to have essentially different primary 
structures. For comparison the structural polyprotein, 
~130, which has been shown to contain the peptides 
of the viral capsid and envelope proteins [9,16],was iso- 
latedfromcells infected with another SFV mutant (ts-3) 
and similarly analysed. The map is shown infig.l(D) 
and can be seen to be quite different from those derived 
from ns155 and ns135. These three proteins thus appear 
to be distinct entities with little or no overlapping of 
amino acid sequences. Since the structural proteins are 
encoded by the 26 S RNA [5,6,8], it follows that if 
the nonstructural proteins are virus coded, they must 
be translated from that part of the 42 S RNA which is 
not duplicated in the 26 S RNA. 
To test this, the wild type 42 S RNA was translated 
in a cell-free protein synthesising system. We selected 
conditions used previously, under which initiation of 
translation on the 42 S RNA started at a single site, 
which was different from that on the 26 S RNA [ 141. 
The tryptic peptide map derived from the whole 
protein synthesising reaction programmed with 42 S 
RNA is shown in fig. 1 (C). The map is strikingly 
similar to that derived from ns155 (fig.l(A)). Detailed 
comparison revealed that all the major peptides 
detected in nsl55 were also present in the in vitro 
product, although their intensities were different. By 
increasing the autoradiographic exposure period, some 
more, but not all, of the peptides of ns135 could also 
be detected in the in vitro product (fig.l(C), inset). 
Peptides present in the control cell-free incubation 
(with no added mRNA) and so presumably due to 
the endogenous synthesis of the system, are indicated. 
These results confirm that nsl55 and most 
probably also ns135 are encoded by the virion 42 S 
RNA. The two nonstructural precursor proteins, 
together with the structural polyprotein ~130, thus 
appear to represent translation of virtually the full 
coding capacity of the SFV 42 S RNA genome. Our 
inability to detect all the peptides of ns135 in the 
42 S RNA directed in vitro product is most simply 
explained if ns155 and ns135 are, as proposed [lo], 
the initial cleavage products of a giant polyprotein 
(mol. wt approx. 290 000). Persistent difficulty has 
been experienced in obtaining full translation of high 
molecular weight proteins in vitro [ 17- 191. The low 
intensities of some, and absence of other ns135 
derived tryptic peptides would reflect the failure of 
the ribosomes in this cell-free system to translate the 
giant polyprotein fully. Conversely, the high intensities 
of certain other peptides in the in vitro product 
(indicated by (+D> in fig. l(C), also reported in [8]), 
which lack counter-parts in ns155 and ns135 suggests 
that they may be proximal to the site for initiation of 
translation. They may represent a ‘lead-in’ sequence 
similar to that proposed for encephalomyocarditis 
virus [20], but more direct evidence for this possibility 
is required. 
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